Literature DB >> 7623883

Beta-adrenergic bronchodilators.

H S Nelson1.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7623883     DOI： 10.1056/NEJM199508243330807

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  37 in total

Review 1.  Asthma--the changing face of drug therapy.

Authors:  J Legg; J Warner
Journal:  Indian J Pediatr       Date:  2000-02       Impact factor: 1.967

Review 2.  Management of asthma in adults: current therapy and future directions.

Authors:  R H Green; C E Brightling; I D Pavord; A J Wardlaw
Journal:  Postgrad Med J       Date:  2003-05       Impact factor: 2.401

3.  A genome-wide association study of bronchodilator response in Latinos implicates rare variants.

Authors:  Katherine A Drake; Dara G Torgerson; Christopher R Gignoux; Joshua M Galanter; Lindsey A Roth; Scott Huntsman; Celeste Eng; Sam S Oh; Sook Wah Yee; Lawrence Lin; Carlos D Bustamante; Andrés Moreno-Estrada; Karla Sandoval; Adam Davis; Luisa N Borrell; Harold J Farber; Rajesh Kumar; Pedro C Avila; Emerita Brigino-Buenaventura; Rocio Chapela; Jean G Ford; Michael A Lenoir; Fred Lurmann; Kelley Meade; Denise Serebrisky; Shannon Thyne; William Rodríguez-Cintrón; Saunak Sen; José R Rodríguez-Santana; Ryan D Hernandez; Kathleen M Giacomini; Esteban G Burchard
Journal:  J Allergy Clin Immunol       Date:  2013-08-29       Impact factor: 10.793

4.  GSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol.

Authors:  Shweta Choudhry; Loretta G Que; Zhonghui Yang; Limin Liu; Celeste Eng; Sung O Kim; Gunjan Kumar; Shannon Thyne; Rocio Chapela; Jose R Rodriguez-Santana; William Rodriguez-Cintron; Pedro C Avila; Jonathan S Stamler; Esteban G Burchard
Journal:  Pharmacogenet Genomics       Date:  2010-06       Impact factor: 2.089

5.  beta-Adrenergic receptor polymorphisms and response to salmeterol.

Authors:  Michael E Wechsler; Erik Lehman; Stephen C Lazarus; Robert F Lemanske; Homer A Boushey; Aaron Deykin; John V Fahy; Christine A Sorkness; Vernon M Chinchilli; Timothy J Craig; Emily DiMango; Monica Kraft; Frank Leone; Richard J Martin; Stephen P Peters; Stanley J Szefler; Wenlei Liu; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2005-12-01       Impact factor: 21.405

Review 6.  Dissecting complex diseases in complex populations: asthma in latino americans.

Authors:  Shweta Choudhry; Max A Seibold; Luisa N Borrell; Hua Tang; Denise Serebrisky; Rocio Chapela; José R Rodriguez-Santana; Pedro C Avila; Elad Ziv; William Rodriguez-Cintron; Neil J Risch; Esteban González Burchard
Journal:  Proc Am Thorac Soc       Date:  2007-07

7.  Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists.

Authors:  R M Martin; N R Dunn; S N Freemantle; R D Mann
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

8.  Beta 2 adrenoceptor polymorphisms: are they clinically important?

Authors:  I P Hall
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

Review 9.  Albuterol. A pharmaceutical chemistry review of R-, S-, and RS-albuterol.

Authors:  R P Bakale; S A Wald; H T Butler; Y Gao; Y Hong; X Nie; C M Zepp
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

10.  Relationship between recent short-acting beta-agonist use and subsequent asthma exacerbations.

Authors:  Jason Paris; Edward L Peterson; Karen Wells; Manel Pladevall; Esteban G Burchard; Shweta Choudhry; David E Lanfear; L Keoki Williams
Journal:  Ann Allergy Asthma Immunol       Date:  2008-11       Impact factor: 6.347
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.